---
title: "Fangsheng Pharmaceutical's subsidiary has received the drug clinical trial approval notice for its traditional Chinese medicine innovation drug research and development project"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252356148.md"
description: "Fangsheng Pharmaceutical's subsidiary Fangsheng Rongke's innovative traditional Chinese medicine research and development project Ziying Granules has recently received the clinical trial approval notice from the National Medical Products Administration. This drug aims to treat the sequelae of pelvic inflammatory disease and is mainly used to alleviate symptoms such as chronic pelvic pain"
datetime: "2025-08-10T07:51:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252356148.md)
  - [en](https://longbridge.com/en/news/252356148.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252356148.md)
---

# Fangsheng Pharmaceutical's subsidiary has received the drug clinical trial approval notice for its traditional Chinese medicine innovation drug research and development project

According to the Zhitong Finance APP, Fangsheng Pharmaceutical (603998.SH) announced that recently, its holding subsidiary Guangdong Fangsheng Rongke Pharmaceutical Co., Ltd. (referred to as "Fangsheng Rongke") received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration for its innovative traditional Chinese medicine research and development project, Ziying Granules.

This product is formulated based on years of clinical experience in treating pelvic inflammatory disease. It is used for the sequelae of pelvic inflammatory diseases - chronic pelvic pain (damp-heat stasis syndrome), with symptoms including dull pain in the lower abdomen, lumbar and sacral distension and pain, increased vaginal discharge that is yellow and thick, low-grade fever with fluctuations, worsening abdominal pain during menstruation, chest tightness and poor appetite, dry mouth, loose stools or constipation, and yellowish-red urine

### Related Stocks

- [603998.CN](https://longbridge.com/en/quote/603998.CN.md)

## Related News & Research

- [Comey eyes new 'anti-weaponization' fund: 'I'm guessing I'll be in line'](https://longbridge.com/en/news/286948735.md)
- [Trump faces record-low approval on inflation as retirees struggle](https://longbridge.com/en/news/286834439.md)
- [09:06 ETHarmony Comes to the Massachusetts State House as The Platters® Prepare Their Musical Love Letter to the World](https://longbridge.com/en/news/286918739.md)
- [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md)
- [13:41 ETUT Haslam Marks Decade in Major International Ranking's Top Five U.S. Public Schools](https://longbridge.com/en/news/286804132.md)